메뉴 건너뛰기




Volumn 8, Issue 3, 2013, Pages

Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE; RAPAMYCIN INSENSITIVE COMPANION OF MTOR PROTEIN; SMALL INTERFERING RNA; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VINCRISTINE;

EID: 84875028952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059597     Document Type: Article
Times cited : (27)

References (94)
  • 1
    • 65349121788 scopus 로고    scopus 로고
    • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-66.
    • (2009) Lancet Oncol , vol.10 , pp. 459-466
    • Stupp, R.1    Hegi, M.E.2    Mason, W.P.3    van den Bent, M.J.4    Taphoorn, M.J.5
  • 3
    • 67649084009 scopus 로고    scopus 로고
    • Targeted therapy for malignant glioma patients: lessons learned and the road ahead
    • Huang TT, Sarkaria SM, Cloughesy TF, Mischel PS, (2009) Targeted therapy for malignant glioma patients: lessons learned and the road ahead. Neurotherapeutics 6: 500-12.
    • (2009) Neurotherapeutics , vol.6 , pp. 500-512
    • Huang, T.T.1    Sarkaria, S.M.2    Cloughesy, T.F.3    Mischel, P.S.4
  • 4
    • 52149096024 scopus 로고    scopus 로고
    • PTEN signaling pathways in glioblastoma
    • Koul D, (2008) PTEN signaling pathways in glioblastoma. Cancer Biol Ther 7: 1321-5.
    • (2008) Cancer Biol Ther , vol.7 , pp. 1321-1325
    • Koul, D.1
  • 6
    • 85027927262 scopus 로고    scopus 로고
    • Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas
    • Li XY, Zhang LQ, Zhang XG, Li X, Ren YB, et al. (2011) Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas. J Neurooncol 103: 453-8.
    • (2011) J Neurooncol , vol.103 , pp. 453-458
    • Li, X.Y.1    Zhang, L.Q.2    Zhang, X.G.3    Li, X.4    Ren, Y.B.5
  • 7
    • 0036094711 scopus 로고    scopus 로고
    • Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival
    • Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, et al. (2002) Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 8: 1100-6.
    • (2002) Clin Cancer Res , vol.8 , pp. 1100-1106
    • Ermoian, R.P.1    Furniss, C.S.2    Lamborn, K.R.3    Basila, D.4    Berger, M.S.5
  • 8
    • 0032558822 scopus 로고    scopus 로고
    • Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
    • Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, et al. (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8: 1195-8.
    • (1998) Curr Biol , vol.8 , pp. 1195-1198
    • Haas-Kogan, D.1    Shalev, N.2    Wong, M.3    Mills, G.4    Yount, G.5
  • 9
    • 77953215319 scopus 로고    scopus 로고
    • Invasive glioblastoma cells acquire stemness and increased Akt activation
    • Molina JR, Hayashi Y, Stephens C, Georgescu MM, (2010) Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia 12: 453-63.
    • (2010) Neoplasia , vol.12 , pp. 453-463
    • Molina, J.R.1    Hayashi, Y.2    Stephens, C.3    Georgescu, M.M.4
  • 10
    • 77949452524 scopus 로고    scopus 로고
    • The PKB/AKT pathway in cancer
    • Carnero A, (2010) The PKB/AKT pathway in cancer. Curr Pharm Des 16: 34-44.
    • (2010) Curr Pharm Des , vol.16 , pp. 34-44
    • Carnero, A.1
  • 11
    • 33747819801 scopus 로고    scopus 로고
    • mTOR and cancer: insights into a complex relationship
    • Sabatini DM, (2006) mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6: 729-34.
    • (2006) Nat Rev Cancer , vol.6 , pp. 729-734
    • Sabatini, D.M.1
  • 12
    • 0038540963 scopus 로고    scopus 로고
    • United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling
    • Manning BD, Cantley LC, (2003) United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem Soc Trans 31: 573-8.
    • (2003) Biochem Soc Trans , vol.31 , pp. 573-578
    • Manning, B.D.1    Cantley, L.C.2
  • 14
    • 70449457461 scopus 로고    scopus 로고
    • Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility
    • Gulati N, Karsy M, Albert L, Murali R, Jhanwar-Uniyal M, (2009) Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Int J Oncol 35: 731-40.
    • (2009) Int J Oncol , vol.35 , pp. 731-740
    • Gulati, N.1    Karsy, M.2    Albert, L.3    Murali, R.4    Jhanwar-Uniyal, M.5
  • 15
    • 23844438209 scopus 로고    scopus 로고
    • Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
    • Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, et al. (2005) Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res 65: 7052-8.
    • (2005) Cancer Res , vol.65 , pp. 7052-7058
    • Sun, S.Y.1    Rosenberg, L.M.2    Wang, X.3    Zhou, Z.4    Yue, P.5
  • 16
    • 32944457518 scopus 로고    scopus 로고
    • mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
    • O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, et al. (2006) mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66: 1500-8.
    • (2006) Cancer Res , vol.66 , pp. 1500-1508
    • O'Reilly, K.E.1    Rojo, F.2    She, Q.B.3    Solit, D.4    Mills, G.B.5
  • 17
    • 13844312400 scopus 로고    scopus 로고
    • Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
    • Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-101.
    • (2005) Science , vol.307 , pp. 1098-1101
    • Sarbassov, D.D.1    Guertin, D.A.2    Ali, S.M.3    Sabatini, D.M.4
  • 18
    • 3342895823 scopus 로고    scopus 로고
    • Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
    • Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, et al. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296-302.
    • (2004) Curr Biol , vol.14 , pp. 1296-1302
    • Sarbassov, D.D.1    Ali, S.M.2    Kim, D.H.3    Guertin, D.A.4    Latek, R.R.5
  • 19
    • 77954235821 scopus 로고    scopus 로고
    • Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
    • Sparks CA, Guertin DA, (2010) Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29: 3733-44.
    • (2010) Oncogene , vol.29 , pp. 3733-3744
    • Sparks, C.A.1    Guertin, D.A.2
  • 20
    • 37549048521 scopus 로고    scopus 로고
    • mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor
    • Masri J, Bernath A, Martin J, Jo OD, Vartanian R, et al. (2007) mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res 67: 11712-20.
    • (2007) Cancer Res , vol.67 , pp. 11712-11720
    • Masri, J.1    Bernath, A.2    Martin, J.3    Jo, O.D.4    Vartanian, R.5
  • 21
    • 0025790916 scopus 로고
    • Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo
    • Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, et al. (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51: 2164-72.
    • (1991) Cancer Res , vol.51 , pp. 2164-2172
    • Ekstrand, A.J.1    James, C.D.2    Cavenee, W.K.3    Seliger, B.4    Pettersson, R.F.5
  • 22
    • 34250877865 scopus 로고    scopus 로고
    • Genetic pathways to primary and secondary glioblastoma
    • Ohgaki H, Kleihues P, (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170: 1445-53.
    • (2007) Am J Pathol , vol.170 , pp. 1445-1453
    • Ohgaki, H.1    Kleihues, P.2
  • 23
    • 33846218204 scopus 로고    scopus 로고
    • Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas
    • Nicholas MK, Lukas RV, Jafri NF, Faoro L, Salgia R, (2006) Epidermal growth factor receptor- mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res 12: 7261-70.
    • (2006) Clin Cancer Res , vol.12 , pp. 7261-7270
    • Nicholas, M.K.1    Lukas, R.V.2    Jafri, N.F.3    Faoro, L.4    Salgia, R.5
  • 24
    • 33947681747 scopus 로고    scopus 로고
    • The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications
    • Nakamura JL, (2007) The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications. Expert Opin Ther Targets 11: 463-72.
    • (2007) Expert Opin Ther Targets , vol.11 , pp. 463-472
    • Nakamura, J.L.1
  • 25
    • 73949083511 scopus 로고    scopus 로고
    • Oncogenic EGFR signaling networks in glioma
    • Huang PH, Xu AM, White FM, (2009) Oncogenic EGFR signaling networks in glioma. Sci Signal 2: re6.
    • (2009) Sci Signal , vol.2
    • Huang, P.H.1    Xu, A.M.2    White, F.M.3
  • 26
    • 77956868654 scopus 로고    scopus 로고
    • Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance
    • Hatanpaa KJ, Burma S, Zhao D, Habib AA, (2010) Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 12: 675-84.
    • (2010) Neoplasia , vol.12 , pp. 675-684
    • Hatanpaa, K.J.1    Burma, S.2    Zhao, D.3    Habib, A.A.4
  • 27
    • 0031961980 scopus 로고    scopus 로고
    • Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor
    • Moscatello DK, Holgado-Madruga M, Emlet DR, Montgomery RB, Wong AJ, (1998) Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem 273: 200-6.
    • (1998) J Biol Chem , vol.273 , pp. 200-206
    • Moscatello, D.K.1    Holgado-Madruga, M.2    Emlet, D.R.3    Montgomery, R.B.4    Wong, A.J.5
  • 28
    • 14444288522 scopus 로고    scopus 로고
    • The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
    • Huang HS, Nagane M, Klingbeil CK, Lin H, Nishikawa R, et al. (1997) The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 272: 2927-35.
    • (1997) J Biol Chem , vol.272 , pp. 2927-2935
    • Huang, H.S.1    Nagane, M.2    Klingbeil, C.K.3    Lin, H.4    Nishikawa, R.5
  • 29
    • 77957937844 scopus 로고    scopus 로고
    • Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies
    • Ahluwalia MS, de Groot J, Liu WM, Gladson CL, (2010) Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies. Cancer Lett 298: 139-49.
    • (2010) Cancer Lett , vol.298 , pp. 139-149
    • Ahluwalia, M.S.1    de Groot, J.2    Liu, W.M.3    Gladson, C.L.4
  • 30
    • 67651154339 scopus 로고    scopus 로고
    • Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
    • Karpel-Massler G, Schmidt U, Unterberg A, Halatsch ME, (2009) Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand? Mol Cancer Res 7: 1000-12.
    • (2009) Mol Cancer Res , vol.7 , pp. 1000-1012
    • Karpel-Massler, G.1    Schmidt, U.2    Unterberg, A.3    Halatsch, M.E.4
  • 31
    • 33847359256 scopus 로고    scopus 로고
    • Targeting malignant glioma survival signalling to improve clinical outcomes
    • Wong ML, Kaye AH, Hovens CM, (2007) Targeting malignant glioma survival signalling to improve clinical outcomes. J Clin Neurosci 14: 301-8.
    • (2007) J Clin Neurosci , vol.14 , pp. 301-308
    • Wong, M.L.1    Kaye, A.H.2    Hovens, C.M.3
  • 32
    • 2542561420 scopus 로고    scopus 로고
    • Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer
    • Zhang Y, Zhang YF, Bryant J, Charles A, Boado RJ, et al. (2004) Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 10: 3667-77.
    • (2004) Clin Cancer Res , vol.10 , pp. 3667-3677
    • Zhang, Y.1    Zhang, Y.F.2    Bryant, J.3    Charles, A.4    Boado, R.J.5
  • 33
    • 12344269275 scopus 로고    scopus 로고
    • RNA interference and nonviral targeted gene therapy of experimental brain cancer
    • Boado RJ, (2005) RNA interference and nonviral targeted gene therapy of experimental brain cancer. NeuroRx 2: 139-50.
    • (2005) NeuroRx , vol.2 , pp. 139-150
    • Boado, R.J.1
  • 34
    • 66249119716 scopus 로고    scopus 로고
    • siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing
    • Verreault M, Bally MB, (2009) siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing. Oligonucleotides 19: 129-40.
    • (2009) Oligonucleotides , vol.19 , pp. 129-140
    • Verreault, M.1    Bally, M.B.2
  • 35
    • 79960455176 scopus 로고    scopus 로고
    • Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumors
    • Verreault M, Strutt D, Masin D, Fink D, Gill R, et al. (2011) Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumors. Anticancer Res 31: 2161-71.
    • (2011) Anticancer Res , vol.31 , pp. 2161-2171
    • Verreault, M.1    Strutt, D.2    Masin, D.3    Fink, D.4    Gill, R.5
  • 36
    • 63849225752 scopus 로고    scopus 로고
    • Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors
    • Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, et al. (2009) Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 69: 3472-81.
    • (2009) Cancer Res , vol.69 , pp. 3472-3481
    • Wakimoto, H.1    Kesari, S.2    Farrell, C.J.3    Curry Jr., W.T.4    Zaupa, C.5
  • 37
    • 0032530482 scopus 로고    scopus 로고
    • Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
    • Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, et al. (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A 95: 11211-6.
    • (1998) Proc Natl Acad Sci U S A , vol.95 , pp. 11211-11216
    • Delcommenne, M.1    Tan, C.2    Gray, V.3    Rue, L.4    Woodgett, J.5
  • 38
    • 31544439674 scopus 로고    scopus 로고
    • Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival
    • Troussard AA, McDonald PC, Wederell ED, Mawji NM, Filipenko NR, et al. (2006) Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res 66: 393-403.
    • (2006) Cancer Res , vol.66 , pp. 393-403
    • Troussard, A.A.1    McDonald, P.C.2    Wederell, E.D.3    Mawji, N.M.4    Filipenko, N.R.5
  • 39
    • 19944411156 scopus 로고    scopus 로고
    • Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth
    • Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, et al. (2005) Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 24: 3596-605.
    • (2005) Oncogene , vol.24 , pp. 3596-3605
    • Edwards, L.A.1    Thiessen, B.2    Dragowska, W.H.3    Daynard, T.4    Bally, M.B.5
  • 40
    • 0034895056 scopus 로고    scopus 로고
    • Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids
    • Grill J, Van Beusechem VW, Van Der Valk P, Dirven CM, Leonhart A, et al. (2001) Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. Clin Cancer Res 7: 641-50.
    • (2001) Clin Cancer Res , vol.7 , pp. 641-650
    • Grill, J.1    Van Beusechem, V.W.2    Van Der Valk, P.3    Dirven, C.M.4    Leonhart, A.5
  • 41
    • 34547637424 scopus 로고    scopus 로고
    • Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo
    • Arwert E, Hingtgen S, Figueiredo JL, Bergquist H, Mahmood U, et al. (2007) Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo. Cancer Res 67: 7335-42.
    • (2007) Cancer Res , vol.67 , pp. 7335-7342
    • Arwert, E.1    Hingtgen, S.2    Figueiredo, J.L.3    Bergquist, H.4    Mahmood, U.5
  • 42
    • 33846213523 scopus 로고    scopus 로고
    • Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity
    • Allen C, Vongpunsawad S, Nakamura T, James CD, Schroeder M, et al. (2006) Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Res 66: 11840-50.
    • (2006) Cancer Res , vol.66 , pp. 11840-11850
    • Allen, C.1    Vongpunsawad, S.2    Nakamura, T.3    James, C.D.4    Schroeder, M.5
  • 43
    • 84859530282 scopus 로고    scopus 로고
    • Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
    • Wakimoto H, Mohapatra G, Kanai R, Curry WT Jr, Yip S, et al. (2012) Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro Oncol 14: 132-44.
    • (2012) Neuro Oncol , vol.14 , pp. 132-144
    • Wakimoto, H.1    Mohapatra, G.2    Kanai, R.3    Curry Jr., W.T.4    Yip, S.5
  • 44
    • 0032977124 scopus 로고    scopus 로고
    • Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines
    • Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, et al. (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9: 469-79.
    • (1999) Brain Pathol , vol.9 , pp. 469-479
    • Ishii, N.1    Maier, D.2    Merlo, A.3    Tada, M.4    Sawamura, Y.5
  • 45
    • 17144398831 scopus 로고    scopus 로고
    • Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis
    • Lefranc F, Brotchi J, Kiss R, (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 2411-22.
    • (2005) J Clin Oncol , vol.23 , pp. 2411-2422
    • Lefranc, F.1    Brotchi, J.2    Kiss, R.3
  • 46
    • 0141618355 scopus 로고    scopus 로고
    • EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2
    • Marcoux N, Vuori K, (2003) EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2. Oncogene 22: 6100-6.
    • (2003) Oncogene , vol.22 , pp. 6100-6106
    • Marcoux, N.1    Vuori, K.2
  • 47
    • 0028089832 scopus 로고
    • Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement
    • Chen P, Xie H, Sekar MC, Gupta K, Wells A, (1994) Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127: 847-57.
    • (1994) J Cell Biol , vol.127 , pp. 847-857
    • Chen, P.1    Xie, H.2    Sekar, M.C.3    Gupta, K.4    Wells, A.5
  • 48
    • 47949104258 scopus 로고    scopus 로고
    • Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
    • Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL, (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. Embo J 27: 1919-31.
    • (2008) Embo J , vol.27 , pp. 1919-1931
    • Ikenoue, T.1    Inoki, K.2    Yang, Q.3    Zhou, X.4    Guan, K.L.5
  • 49
    • 47949125486 scopus 로고    scopus 로고
    • The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
    • Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. Embo J. 27: 1932-43.
    • (2008) Embo J , vol.27 , pp. 1932-1943
    • Facchinetti, V.1    Ouyang, W.2    Wei, H.3    Soto, N.4    Lazorchak, A.5
  • 50
    • 33751348056 scopus 로고    scopus 로고
    • Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1
    • Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, et al. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11: 859-71.
    • (2006) Dev Cell , vol.11 , pp. 859-871
    • Guertin, D.A.1    Stevens, D.M.2    Thoreen, C.C.3    Burds, A.A.4    Kalaany, N.Y.5
  • 52
    • 61849087971 scopus 로고    scopus 로고
    • Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells
    • Guo H, Gu F, Li W, Zhang B, Niu R, et al. (2009) Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. J Neurochem 109: 203-13.
    • (2009) J Neurochem , vol.109 , pp. 203-213
    • Guo, H.1    Gu, F.2    Li, W.3    Zhang, B.4    Niu, R.5
  • 53
    • 16544370071 scopus 로고    scopus 로고
    • Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
    • Brandes AA, Tosoni A, Basso U, Reni M, Valduga F, et al. (2004) Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). J Clin Oncol 22: 4779-86.
    • (2004) J Clin Oncol , vol.22 , pp. 4779-4786
    • Brandes, A.A.1    Tosoni, A.2    Basso, U.3    Reni, M.4    Valduga, F.5
  • 54
    • 18344374653 scopus 로고    scopus 로고
    • Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience
    • Turner CD, Gururangan S, Eastwood J, Bottom K, Watral M, et al. (2002) Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience. Neuro Oncol 4: 102-8.
    • (2002) Neuro Oncol , vol.4 , pp. 102-108
    • Turner, C.D.1    Gururangan, S.2    Eastwood, J.3    Bottom, K.4    Watral, M.5
  • 56
    • 77749338221 scopus 로고    scopus 로고
    • Recent advances in therapy for glioblastoma
    • Clarke J, Butowski N, Chang S, (2010) Recent advances in therapy for glioblastoma. Arch Neurol 67: 279-83.
    • (2010) Arch Neurol , vol.67 , pp. 279-283
    • Clarke, J.1    Butowski, N.2    Chang, S.3
  • 57
    • 58649092475 scopus 로고    scopus 로고
    • mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
    • Garcia-Martinez JM, Alessi DR, (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416: 375-85.
    • (2008) Biochem J , vol.416 , pp. 375-385
    • Garcia-Martinez, J.M.1    Alessi, D.R.2
  • 58
    • 28944448745 scopus 로고    scopus 로고
    • ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model
    • Arao T, Yanagihara K, Takigahira M, Takeda M, Koizumi F, et al. (2006) ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer 118: 483-9.
    • (2006) Int J Cancer , vol.118 , pp. 483-489
    • Arao, T.1    Yanagihara, K.2    Takigahira, M.3    Takeda, M.4    Koizumi, F.5
  • 59
    • 23944453425 scopus 로고    scopus 로고
    • Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study
    • Galanis E, Buckner JC, Maurer MJ, Kreisberg JI, Ballman K, et al. (2005) Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol 23: 5294-304.
    • (2005) J Clin Oncol , vol.23 , pp. 5294-5304
    • Galanis, E.1    Buckner, J.C.2    Maurer, M.J.3    Kreisberg, J.I.4    Ballman, K.5
  • 60
    • 21044431575 scopus 로고    scopus 로고
    • Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
    • Chang SM, Wen P, Cloughesy T, Greenberg H, Schiff D, et al. (2005) Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs 23: 357-61.
    • (2005) Invest New Drugs , vol.23 , pp. 357-361
    • Chang, S.M.1    Wen, P.2    Cloughesy, T.3    Greenberg, H.4    Schiff, D.5
  • 62
    • 75749122223 scopus 로고    scopus 로고
    • A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
    • Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, et al. (2010) A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro Oncol 12: 95-103.
    • (2010) Neuro Oncol , vol.12 , pp. 95-103
    • Raizer, J.J.1    Abrey, L.E.2    Lassman, A.B.3    Chang, S.M.4    Lamborn, K.R.5
  • 63
    • 78049306732 scopus 로고    scopus 로고
    • Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
    • Yung WK, Vredenburgh JJ, Cloughesy TF, Nghiemphu P, Klencke B, et al. (2010) Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study. Neuro Oncol 12: 1061-70.
    • (2010) Neuro Oncol , vol.12 , pp. 1061-1070
    • Yung, W.K.1    Vredenburgh, J.J.2    Cloughesy, T.F.3    Nghiemphu, P.4    Klencke, B.5
  • 65
    • 59349089499 scopus 로고    scopus 로고
    • A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)
    • Kreisl TN, Lassman AB, Mischel PS, Rosen N, Scher HI, et al. (2009) A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). J Neurooncol 92: 99-105.
    • (2009) J Neurooncol , vol.92 , pp. 99-105
    • Kreisl, T.N.1    Lassman, A.B.2    Mischel, P.S.3    Rosen, N.4    Scher, H.I.5
  • 66
    • 69949106925 scopus 로고    scopus 로고
    • The double-edged sword of autophagy modulation in cancer
    • White E, DiPaola RS, (2009) The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15: 5308-16.
    • (2009) Clin Cancer Res , vol.15 , pp. 5308-5316
    • White, E.1    DiPaola, R.S.2
  • 67
    • 4644359805 scopus 로고    scopus 로고
    • Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase
    • Feng J, Park J, Cron P, Hess D, Hemmings BA, (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279: 41189-96.
    • (2004) J Biol Chem , vol.279 , pp. 41189-41196
    • Feng, J.1    Park, J.2    Cron, P.3    Hess, D.4    Hemmings, B.A.5
  • 68
    • 2442562698 scopus 로고    scopus 로고
    • Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells
    • Partovian C, Simons M, (2004) Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells. Cell Signal 16: 951-7.
    • (2004) Cell Signal , vol.16 , pp. 951-957
    • Partovian, C.1    Simons, M.2
  • 69
    • 0033594480 scopus 로고    scopus 로고
    • PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2
    • Balendran A, Casamayor A, Deak M, Paterson A, Gaffney P, et al. (1999) PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol 9: 393-404.
    • (1999) Curr Biol , vol.9 , pp. 393-404
    • Balendran, A.1    Casamayor, A.2    Deak, M.3    Paterson, A.4    Gaffney, P.5
  • 70
    • 0034708482 scopus 로고    scopus 로고
    • Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
    • Toker A, Newton AC, (2000) Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 275: 8271-4.
    • (2000) J Biol Chem , vol.275 , pp. 8271-8274
    • Toker, A.1    Newton, A.C.2
  • 71
    • 79955731315 scopus 로고    scopus 로고
    • Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells
    • Das G, Shiras A, Shanmuganandam K, Shastry P, (2011) Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. Mol Carcinog 50: 412-23.
    • (2011) Mol Carcinog , vol.50 , pp. 412-423
    • Das, G.1    Shiras, A.2    Shanmuganandam, K.3    Shastry, P.4
  • 72
    • 0036855463 scopus 로고    scopus 로고
    • Protein kinase C alpha (PKC alpha): regulation and biological function
    • Nakashima S, (2002) Protein kinase C alpha (PKC alpha): regulation and biological function. J Biochem 132: 669-75.
    • (2002) J Biochem , vol.132 , pp. 669-675
    • Nakashima, S.1
  • 74
    • 34247218483 scopus 로고    scopus 로고
    • Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
    • Franceschi E, Cavallo G, Lonardi S, Magrini E, Tosoni A, et al. (2007) Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Br J Cancer 96: 1047-51.
    • (2007) Br J Cancer , vol.96 , pp. 1047-1051
    • Franceschi, E.1    Cavallo, G.2    Lonardi, S.3    Magrini, E.4    Tosoni, A.5
  • 75
    • 50649103493 scopus 로고    scopus 로고
    • Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
    • de Groot JF, Gilbert MR, Aldape K, Hess KR, Hanna TA, et al. (2008) Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma. J Neurooncol 90: 89-97.
    • (2008) J Neurooncol , vol.90 , pp. 89-97
    • de Groot, J.F.1    Gilbert, M.R.2    Aldape, K.3    Hess, K.R.4    Hanna, T.A.5
  • 76
    • 79952111297 scopus 로고    scopus 로고
    • Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance
    • Fan QW, Weiss WA, (2010) Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance. Curr Top Microbiol Immunol 347: 279-96.
    • (2010) Curr Top Microbiol Immunol , vol.347 , pp. 279-296
    • Fan, Q.W.1    Weiss, W.A.2
  • 77
    • 33747099671 scopus 로고    scopus 로고
    • Effective silencing of EGFR with RNAi demonstrates non-EGFR dependent proliferation of glioma cells
    • Vollmann A, Vornlocher HP, Stempfl T, Brockhoff G, Apfel R, et al. (2006) Effective silencing of EGFR with RNAi demonstrates non-EGFR dependent proliferation of glioma cells. Int J Oncol 28: 1531-42.
    • (2006) Int J Oncol , vol.28 , pp. 1531-1542
    • Vollmann, A.1    Vornlocher, H.P.2    Stempfl, T.3    Brockhoff, G.4    Apfel, R.5
  • 78
    • 0346690261 scopus 로고    scopus 로고
    • Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach
    • Fan QW, Specht KM, Zhang C, Goldenberg DD, Shokat KM, et al. (2003) Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach. Cancer Res 63: 8930-8.
    • (2003) Cancer Res , vol.63 , pp. 8930-8938
    • Fan, Q.W.1    Specht, K.M.2    Zhang, C.3    Goldenberg, D.D.4    Shokat, K.M.5
  • 79
    • 33748058820 scopus 로고    scopus 로고
    • Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells
    • Wang MY, Lu KV, Zhu S, Dia EQ, Vivanco I, et al. (2006) Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res 66: 7864-9.
    • (2006) Cancer Res , vol.66 , pp. 7864-7869
    • Wang, M.Y.1    Lu, K.V.2    Zhu, S.3    Dia, E.Q.4    Vivanco, I.5
  • 80
    • 33644877965 scopus 로고    scopus 로고
    • Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells
    • Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, et al. (2005) Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells. Neoplasia 7: 921-9.
    • (2005) Neoplasia , vol.7 , pp. 921-929
    • Rao, R.D.1    Mladek, A.C.2    Lamont, J.D.3    Goble, J.M.4    Erlichman, C.5
  • 81
    • 33645878924 scopus 로고    scopus 로고
    • Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo
    • Kang CS, Zhang ZY, Jia ZF, Wang GX, Qiu MZ, et al. (2006) Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 13: 530-8.
    • (2006) Cancer Gene Ther , vol.13 , pp. 530-538
    • Kang, C.S.1    Zhang, Z.Y.2    Jia, Z.F.3    Wang, G.X.4    Qiu, M.Z.5
  • 82
    • 0031752773 scopus 로고    scopus 로고
    • Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation
    • Tian XX, Lam PY, Chen J, Pang JC, To SS, et al. (1998) Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation. Neuropathol Appl Neurobiol 24: 389-96.
    • (1998) Neuropathol Appl Neurobiol , vol.24 , pp. 389-396
    • Tian, X.X.1    Lam, P.Y.2    Chen, J.3    Pang, J.C.4    To, S.S.5
  • 83
    • 27744519930 scopus 로고    scopus 로고
    • Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo
    • Saydam O, Glauser DL, Heid I, Turkeri G, Hilbe M, et al. (2005) Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Mol Ther 12: 803-12.
    • (2005) Mol Ther , vol.12 , pp. 803-812
    • Saydam, O.1    Glauser, D.L.2    Heid, I.3    Turkeri, G.4    Hilbe, M.5
  • 84
    • 0036141447 scopus 로고    scopus 로고
    • Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling
    • Chakravarti A, Loeffler JS, Dyson NJ, (2002) Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res 62: 200-7.
    • (2002) Cancer Res , vol.62 , pp. 200-207
    • Chakravarti, A.1    Loeffler, J.S.2    Dyson, N.J.3
  • 85
    • 72449198117 scopus 로고    scopus 로고
    • The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors
    • Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, et al. (2009) The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors. Mol Cancer Res 7: 1736-43.
    • (2009) Mol Cancer Res , vol.7 , pp. 1736-1743
    • Rho, J.K.1    Choi, Y.J.2    Lee, J.K.3    Ryoo, B.Y.4    Na, I.I.5
  • 86
    • 7444231680 scopus 로고    scopus 로고
    • RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival
    • Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, et al. (2004) RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival. Cancer Res 64: 7962-70.
    • (2004) Cancer Res , vol.64 , pp. 7962-7970
    • Shinomiya, N.1    Gao, C.F.2    Xie, Q.3    Gustafson, M.4    Waters, D.J.5
  • 87
    • 3042673613 scopus 로고    scopus 로고
    • Molecular biology of gliomas
    • Lassman AB, (2004) Molecular biology of gliomas. Curr Neurol Neurosci Rep 4: 228-33.
    • (2004) Curr Neurol Neurosci Rep , vol.4 , pp. 228-233
    • Lassman, A.B.1
  • 88
    • 0141542627 scopus 로고    scopus 로고
    • Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells
    • Kruger JS, Reddy KB, (2003) Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Mol Cancer Res 1: 801-9.
    • (2003) Mol Cancer Res , vol.1 , pp. 801-809
    • Kruger, J.S.1    Reddy, K.B.2
  • 89
    • 84860816141 scopus 로고    scopus 로고
    • Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance
    • Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, et al. (2011) Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance. Cancer Discov 1: 524-38.
    • (2011) Cancer Discov , vol.1 , pp. 524-538
    • Tanaka, K.1    Babic, I.2    Nathanson, D.3    Akhavan, D.4    Guo, D.5
  • 90
    • 70349974841 scopus 로고    scopus 로고
    • The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair
    • Westhoff MA, Kandenwein JA, Karl S, Vellanki SH, Braun V, et al. (2009) The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair. Oncogene 28: 3586-96.
    • (2009) Oncogene , vol.28 , pp. 3586-3596
    • Westhoff, M.A.1    Kandenwein, J.A.2    Karl, S.3    Vellanki, S.H.4    Braun, V.5
  • 91
    • 77954341696 scopus 로고    scopus 로고
    • Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
    • Krakstad C, Chekenya M, (2010) Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 9: 135.
    • (2010) Mol Cancer , vol.9 , pp. 135
    • Krakstad, C.1    Chekenya, M.2
  • 92
    • 34547410311 scopus 로고    scopus 로고
    • Cellular responses to EGFR inhibitors and their relevance to cancer therapy
    • Dutta PR, Maity A, (2007) Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Cancer Lett 254: 165-77.
    • (2007) Cancer Lett , vol.254 , pp. 165-177
    • Dutta, P.R.1    Maity, A.2
  • 93
    • 52749087584 scopus 로고    scopus 로고
    • Brain tumour stem cells: implications for cancer therapy and regenerative medicine
    • Sanchez-Martin M, (2008) Brain tumour stem cells: implications for cancer therapy and regenerative medicine. Curr Stem Cell Res Ther 3: 197-207.
    • (2008) Curr Stem Cell Res Ther , vol.3 , pp. 197-207
    • Sanchez-Martin, M.1
  • 94
    • 58749089674 scopus 로고    scopus 로고
    • The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence
    • Liu JM, Mao BY, Hong S, Liu YH, Wang XJ, (2008) The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence. Adv Ther 25: 389-98.
    • (2008) Adv Ther , vol.25 , pp. 389-398
    • Liu, J.M.1    Mao, B.Y.2    Hong, S.3    Liu, Y.H.4    Wang, X.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.